Pfizer Ducks End-Payors' Lipitor Antitrust Claims
A New Jersey federal judge on Thursday dismissed antitrust claims brought by indirect buyers of Lipitor in multidistrict litigation alleging Pfizer Inc. and Ranbaxy Laboratories Ltd. entered an anti-competitive patent infringement...To view the full article, register now.
Already a subscriber? Click here to view full article